Clinical Trial Update: INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial evaluating INK Cells as maintenance therapy after chemoradiotherapy in small cell lung cancer, with enrollment currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• iNK Cells (induced natural killer cells)

Snippet

Sponsor: Guangzhou Ruixin Biotechnological Co., LTD | Conditions: Small Cell Lung Cancer | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION